Triple Your Impact This Holiday Season
Triple Your Impact This Holiday Season
Celebrate the holidays with a year-end gift that can go 3x as far to help provide care and support to the millions affected by Alzheimer's disease, and to advance critical research. But please hurry — this 3x Match Challenge ends soon.
Donate NowLocal experts react to FDA approval of blood test biomarker for early Alzheimer’s detection
In May, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of the disease.
WPXI-TV spoke with those fighting for a cure here in the Pittsburgh area. Sara Murphy, vice president for programs and services for the Greater Pennsylvania chapter of the Alzheimer’s Association, said while there’s still work to be done, this FDA clearance is a huge step for early detection.
Full Story: https://www.wpxi.com/news/local/local-experts-react-fda-approval-blood-test-biomarker-early-alzheimers-detection/ZGPJH4CVJVFWPD6NPVK2MMVBAU/